$90.84
+1.91 (+2.15%)
POST News30 articles
Boxlight Shares Surge Post Reverse Split, Shareholder Vote Looms
Boxlight shares surged 66% to $5.91 after a reverse split, with a July 7 vote on raising authorized shares, but the company flagged substantial doubt about its viability.
Bezos Reportedly Called Washington Post 'Worst Investment' to Trump
A forthcoming book alleges Jeff Bezos told Donald Trump in December 2024 that buying The Washington Post was his worst investment, amid major layoffs and business struggles.
IceCure Medical Soars on 70% U.S. ProSense Install Base Growth Post-FDA Clearance
IceCure Medical shares tripled on news of a 70% U.S. install base growth for its ProSense breast cancer cryoablation system following FDA clearance.
ARK Invest Pours $500M into SpaceX Post-IPO, Sells Tesla and AMD
ARK Invest buys over $500 million in SpaceX shares post-IPO, selling Tesla, AMD, Robinhood, and Teradyne to fund the move. SpaceX stock hit $225.38 intraday.
Keel Infrastructure Rises as ATB Reaffirms Bullish Stance Post $458M Financing
KEEL closed at $5.66, up 1.25%, after ATB Capital Markets resumed coverage with an Outperform rating and $10 target, citing the company's $458 million convertible-note financing for AI and HPC data-center growth.
Elon Musk's Net Worth Nears $1.2 Trillion as SpaceX Surges Post-IPO
SpaceX shares jumped 27.5% above the $135 IPO price to $172.16, valuing the company at $2.26 trillion and boosting Elon Musk's net worth to as high as $1.20 trillion.
GameStop Posts Record Profit, Unveils $2B Buyback Amid eBay Pursuit
GameStop posted record Q1 net income of $389.6 million, driven by collectibles, and announced a $2 billion buyback. Shares jumped 7.4% after hours.
Home Depot's Post-Earnings Rally Faces Key Macro Test Next Week
Home Depot shares fell 1.27% Friday despite a 4.8% sales rise, as housing affordability and consumer uncertainty weigh. Next week's economic data could determine the stock's near-term direction.
FTSE 100 Posts Consecutive Monthly Gains, June Awaits Data and Ceasefire Outcome
FTSE 100 slipped 0.16% Friday but secured a 0.3% monthly gain in May. FTSE 250 surged 4.3% for the month. Ocado shares rallied after Asda selected it for an e-commerce upgrade.
VGT's AI-Heavy Portfolio Drives Post-Split Outperformance
Vanguard's Information Technology ETF (VGT) has outperformed its larger growth peers since an April 8-for-1 split, driven by dominant positions in Nvidia, Apple, and Microsoft.
UiPath Posts First GAAP Profit, AI Push Fails to Lift PATH Stock
UiPath shares slid 2.85% in premarket trading Friday after reporting Q1 revenue of $418 million and its first GAAP-profitable quarter. Investors are still weighing AI's impact on long-term sales growth.
NIO's Post-Holiday Trading Begins with ES9 Launch and Profit Goals in Focus
NIO's U.S.-listed shares fell 7.1% ahead of Memorial Day. The company launches its ES9 electric SUV in China on Wednesday, targeting Q2 deliveries of 110,000-115,000 units.
US Futures Advance Post-Holiday; AI Chip Stocks Rally, Iran Talks Eyed
US stock futures climbed Tuesday, with chip stocks rallying as markets reopened after Memorial Day. Investors eye Iran talks and consumer confidence data.
NIO Shares End Flat as Market Awaits Post-Earnings Catalysts
NIO shares ended Friday down 7.14% at $5.20, even as U.S. markets rallied. The stock faces headwinds from fierce competition and macro uncertainty, with key catalysts including the ES9 launch and upcoming inflation data.
Qualcomm Surges on Stellantis Auto Tech Pact; Market Awaits Post-Holiday Trading
Qualcomm shares surged 11.6% Friday to $238.16 after Stellantis expanded its Snapdragon Digital Chassis deal. Automotive revenue rose 38% to $1.33 billion. Markets closed Monday for Memorial Day.
Opendoor Edges Higher as Post-Holiday Housing Data Awaited
Opendoor Technologies shares closed at $4.53, up 3.4% for the week. The market awaits April new home sales data as mortgage rates climb and housing signals remain mixed.
Medline's $2.7B Secondary Offering Tests Post-IPO Demand
Medline Inc. shareholders sold 72.55 million Class A shares at $37 each in an upsized secondary offering, with the stock closing at $37.01 on Friday. The deal closes May 28.
Medline's $2.7B Secondary Offering Tests Post-IPO Demand
Medline's $2.68 billion secondary offering, upsized from 60 million shares, prices at $37 each, with the stock holding near that level.
e.l.f. Beauty Posts Strong Q4 but Warns on 2027 Outlook
e.l.f. Beauty beat Q4 estimates with $449.3M in sales but forecast fiscal 2027 below expectations due to potential $15-$20M oil-related costs.
Pinterest Shares Slide 6%, Wiping Out Post-Earnings Rally
Pinterest shares fell about 6% Tuesday, erasing post-earnings gains, despite Q1 revenue growth and a Q2 forecast above analyst expectations.
Plug Power Shares Slide 9.8% as Post-Earnings Rally Fades
Plug Power shares dropped 9.8% to $3.41 on Monday, retreating from a post-earnings rally as concerns over losses and cash burn persist.
Ambev's Post-Earnings Rally Stalls; World Cup Hopes Tested Next Week
Ambev shares fell 0.51% on Friday, pausing after a strong Q1 earnings report. Investors now focus on the World Cup's potential to boost beer demand, with the stock up 13.2% YTD.
J&J Stock Dips on Friday but Posts Weekly Gain; Key Catalysts Ahead
J&J shares fell 1.77% Friday amid a broad selloff but still gained 2.4% for the week. Next week, investors watch pipeline data and a medtech launch.
Uber Stock Closes Higher but Ends Week Flat as Post-Earnings Momentum Wanes
Uber shares ended the week nearly flat at $75.09 after an 8.53% post-earnings jump faded, as investors weigh strong demand against rising costs and autonomous vehicle investments.
Zoetis Hits New 52-Week Low Amid Steep Post-Earnings Decline
Zoetis closed at $74.22 on Friday, hitting a new 52-week low of $72.38, as the stock continues to slide following disappointing Q1 earnings and a reduced 2026 outlook.
HCW Biologics Posts Profit on China Deal, Faces Nasdaq and Pipeline Tests
HCW Biologics posted a $3.47M profit in Q1 2026, driven by a licensing deal with Trimmune Biotech. The company still trades below Nasdaq's $1 minimum and awaits early human data for its lead alopecia drug.
Xanadu Quantum Posts Wider Loss in First Public Earnings Report
Xanadu Quantum Technologies posted Q1 revenue of $2.8M, up from $0.7M a year ago, but net loss widened to $20.6M. Shares fell over 3% after hours.
Klarna Reports First Profit Post-IPO, Tepid Q2 Guidance Caps Rally
Klarna achieved its first quarterly profit since going public, but softer Q2 guidance tempered investor enthusiasm. Revenue surged 44% to $1 billion.
Keel Infrastructure Posts $128M Q1 Loss, Pushes AI Data-Center Leasing
Keel Infrastructure Corp posted a $128M Q1 loss as legacy revenue fell 23% to $37M. The company has $533M in liquidity to support leasing at three AI data-center sites in North America.
GameStop Shares Swing Wildly After Roaring Kitty X Account Posts Then Deletes Crypto Content
GameStop shares surged up to 13% after posts appeared on Keith Gill's Roaring Kitty X account, then erased gains as the posts vanished within an hour, sparking speculation the account was hacked.